AUTHORS

Bret Jensen
Recent Articles By The Author
Unicorns and Plow Horses
"The difference between a politician and a statesman is that a politician thinks about the next election while the statesman thinks about the next generation." --James Freeman Clarke It is good to be sitting for Doug Kass here on this Friday. Hopefu...
I'm Unapologetically Overweight in These 2 Sectors
The two are homebuilding and biotech, and there are stocks within those sectors where I've parked my money.
Here's Why I'm Underweighting a Number of Market Sectors
Finding the right stocks is like finding the right dance partner.
2 Sagging Stocks That Could Make Good Covered Call Plays
Camping World and American Airlines have had tough years but looks like call option candidates as their prospects improve.
See You in October
It was a good day to fill in for Doug Kass on the Daily Diary as all the major indices ended up in the green to start off the new trading week and as we close out the third quarter. Where does the time go? Lots of good conversation today about stock...
Homebuilders and Refiners Flex Their Muscles Plus a Big Insider Buy
Markets are still nicely in the black for the day with approximately two hours to close. The SPDR Biotech ETF has had a nice reversal since our last update off oversold levels and is now in the green. This is certainly good to see as there was no l...
Can the Hard Hit Bounce Back?
The rally has gained some strength since our last update as all the major indices have moved further in the black. However, we are seeing weakness in a lot of small biotech names as well as plenty of small E&P concerns despite the overall upward til...
Quick Takes on Small-Caps
Stocks are off to a decent start in a new trading week. All the major indices are slightly in the green an hour and a half into the trading day. Here are a few quick takes on some small-caps today. RV maker Thor Industries is up more than 15% in ea...
3 Biotech Plays That Would Work as Covered Calls
The SPDR S&P Biotech ETF, Alexion Pharmaceuticals and BioMarin Pharmaceuticals set up nicely for this options strategy.
Oops!
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Please Join or Log In to Email Our Authors.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login